TABLE 2.
Antiviral activities of CCR5 mAbsa
| Assay | Avg IC50 (μg/ml) ± SD
|
|||||||
|---|---|---|---|---|---|---|---|---|
| 2D7 | ROAb10 | ROAb13 | ROAb18 | ROAb14 | ROAb12 | ROAb36 | ROAb51 | |
| CCF | 0.73 ± 0.18 | 1.62 ± 0.54 | 2.10 ± 0.67 | 0.33 ± 0.13 | 0.20 ± 0.07 | 0.51 ± 0.14 | 23.6 ± 5.29 | 0.86 ± 0.20 |
| Single-cycle antiviral | 1.7 ± 0.57 | 1.74 ± 0.64 | 4.33 ± 1.7 | 0.17 ± 0.03 | 0.16 ± 0.04 | 0.18 ± 0.04 | 17.2 ± 4.37 | 0.73 ± 0.17 |
| PBMC antiviral | 0.34 ± 0.08 | 0.52 ± 0.12 | 0.03 ± 0.03 | 0.02 ± 0.01 | 0.02 ± 0.02 | 0.04 ± 0.03 | 4.6 ± 0.77 | 0.29 ± 0.09 |
Data are averages and standard errors from two or more independent experiments.